181 related articles for article (PubMed ID: 30476230)
1. Expression of the DNA-dependent protein kinase catalytic subunit is associated with the radiosensitivity of human thyroid cancer cell lines.
Ihara M; Ashizawa K; Shichijo K; Kudo T
J Radiat Res; 2019 Mar; 60(2):171-177. PubMed ID: 30476230
[TBL] [Abstract][Full Text] [Related]
2. Relationship between thyroid tumor radiosensitivity and nuclear localization of DNA-dependent protein kinase catalytic subunit.
Ihara M; Shichijo K; Ashizawa K; Matsuda K; Otsubo R; Horie I; Nakashima M; Kudo T
J Radiat Res; 2020 Jul; 61(4):511-516. PubMed ID: 32567663
[TBL] [Abstract][Full Text] [Related]
3. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
Gustafsson AS; Abramenkovs A; Stenerlöw B
Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
[TBL] [Abstract][Full Text] [Related]
4. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].
Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH
Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748
[TBL] [Abstract][Full Text] [Related]
5. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ
Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of DNA-dependent protein kinase catalytic subunit expression to radiosensitivity of non-small cell lung cancer cell lines].
Pan Y; Li WX; Li JM; Zhu JQ; Liang YQ; Guo AL
Ai Zheng; 2009 Jul; 28(7):714-7. PubMed ID: 19624897
[TBL] [Abstract][Full Text] [Related]
7. DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells.
Dolman ME; van der Ploeg I; Koster J; Bate-Eya LT; Versteeg R; Caron HN; Molenaar JJ
PLoS One; 2015; 10(12):e0145744. PubMed ID: 26716839
[TBL] [Abstract][Full Text] [Related]
8. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
[TBL] [Abstract][Full Text] [Related]
9. DNA-PKcs-dependent modulation of cellular radiosensitivity by a selective cyclooxygenase-2 inhibitor.
Kodym E; Kodym R; Chen BP; Chen DJ; Morotomi-Yano K; Choy H; Saha D
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):187-93. PubMed ID: 17707272
[TBL] [Abstract][Full Text] [Related]
10. NU7441 Enhances the Radiosensitivity of Liver Cancer Cells.
Yang C; Wang Q; Liu X; Cheng X; Jiang X; Zhang Y; Feng Z; Zhou P
Cell Physiol Biochem; 2016; 38(5):1897-905. PubMed ID: 27160694
[TBL] [Abstract][Full Text] [Related]
11. Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.
Xu JY; Lu S; Xu XY; Hu SL; Li B; Qi RX; Chen L; Chang JY
Asian Pac J Cancer Prev; 2015; 16(8):3301-6. PubMed ID: 25921135
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
13. Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells.
Zhuang L; Cao Y; Xiong H; Gao Q; Cao Z; Liu F; Qiu H; Yu S; Huang X
Int J Oncol; 2011 Aug; 39(2):443-51. PubMed ID: 21573502
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E
Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting DNA-PK
Mamo T; Mladek AC; Shogren KL; Gustafson C; Gupta SK; Riester SM; Maran A; Galindo M; van Wijnen AJ; Sarkaria JN; Yaszemski MJ
Biochem Biophys Res Commun; 2017 Apr; 486(2):307-313. PubMed ID: 28300555
[TBL] [Abstract][Full Text] [Related]
16. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract][Full Text] [Related]
17. DNA-dependent protein kinase activity and radiosensitivity of nasopharyngeal carcinoma cell lines CNE1/CNE2.
He YX; Zhong PP; Yan SS; Liu L; Shi HL; Zeng MS; Xia YF
Sheng Li Xue Bao; 2007 Aug; 59(4):524-33. PubMed ID: 17700973
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
[TBL] [Abstract][Full Text] [Related]
19. DNA-PK inhibition causes a low level of H2AX phosphorylation and homologous recombination repair in Medaka (Oryzias latipes) cells.
Urushihara Y; Kobayashi J; Matsumoto Y; Komatsu K; Oda S; Mitani H
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):131-6. PubMed ID: 23142596
[TBL] [Abstract][Full Text] [Related]
20. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.
Toulany M; Kasten-Pisula U; Brammer I; Wang S; Chen J; Dittmann K; Baumann M; Dikomey E; Rodemann HP
Clin Cancer Res; 2006 Jul; 12(13):4119-26. PubMed ID: 16818713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
